Montz Harcus Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-232
Closed -$249K 95
2025
Q4
$249K Buy
+232
New +$222K 0.1% 76
2024
Q4
Sell
-249
Closed -$221K 79
2024
Q3
$221K Sell
249
-1
-0.4% -$899 0.13% 68
2024
Q2
$226K Sell
250
-11
-4% -$8.8K 0.15% 56
2024
Q1
$203K Buy
+261
New +$186K 0.14% 69

Other funds holding LLY

Montz Harcus Wealth Management's LLY Position: Q1 2026 in Review

Montz Harcus Wealth Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 232 shares — an estimated $249K sold.

Montz Harcus Wealth Management first reported a position in LLY in Q1 2024 and held it in 4 quarters. The position peaked at $249K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Montz Harcus Wealth Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Montz Harcus Wealth Management sold 232 Eli Lilly shares in Q1 2026, an estimated $249K.
  • Montz Harcus Wealth Management first reported a position in Eli Lilly in Q1 2024 and held it in 4 quarters.
  • Montz Harcus Wealth Management's Eli Lilly position peaked at $249K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Montz Harcus Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.